If the powers that be at Mesoblast can't do a CHF partnership with what's on offer for Rexlemestrocel-L now through both pediatrics and adults then we need new management .... simples .... that's the post
GLTAH
Ann: Annual Financial Results Presentation, page-27
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.025(1.88%) |
Mkt cap ! $1.547B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.40 | $1.34 | $3.430M | 2.517M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 35426 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 27745 | 7 |
View Market Depth
| Last trade - 15.49pm 07/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |